These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3602324)

  • 21. [Efficacy of verapamil in severe hypertension and hypertensive emergencies].
    Zanolli MB; Herdoiza GL; Padolan E; Mulinari AS; Lassitte A; Branco BP; Marks SC; Rocha de Carvalho JG
    Arq Bras Cardiol; 1982 Sep; 39(3):193-6. PubMed ID: 7186365
    [No Abstract]   [Full Text] [Related]  

  • 22. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of schizophrenia with verapamil.
    Price WA; Pascarzi G; Giannini AJ
    J Clin Psychopharmacol; 1986 Aug; 6(4):249. PubMed ID: 3734147
    [No Abstract]   [Full Text] [Related]  

  • 24. High doses of clorotepin in chronic schizophrenia (preliminary report).
    Bastecký J; Kalvach Z; Hálková E; Tosovský J
    Agressologie; 1980; 21(A):31-5. PubMed ID: 6894669
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
    Deverteuil R; Lehmann HE; Ban TA; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):219-22. PubMed ID: 5550418
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic therapy for chronic schizophrenia.
    Ayd FJ
    Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antipsychotic effects of caerulein on chronic schizophrenia].
    Moroharu T; Watanabe N; Ito M
    Seishin Shinkeigaku Zasshi; 1983; 85(9):611-5. PubMed ID: 6145173
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of thiothixene in the therapy of chronic schizophrenia].
    Romaszewska K; Piotrowski A
    Psychiatr Pol; 1970; 4(1):69-71. PubMed ID: 5421205
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of verapamil on cardiac performance].
    Câmpeanu A; Cerin G; Chira R; Pleşa O; Chirilă L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):87-96. PubMed ID: 6145210
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacotherapy of chronic hospitalized schizophrenics: diagnosis and treatment.
    Ban TA; Guy W; Wilson WH
    Psychiatr J Univ Ott; 1984 Dec; 9(4):191-5. PubMed ID: 6151202
    [No Abstract]   [Full Text] [Related]  

  • 32. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 33. [Verapamil for regulation of cardiac rhythm disorders. Experience with our own patients].
    Arsov D; Serafimova E
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1290+. PubMed ID: 4098330
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the drug 1-methyl-D-lysergic acid butanolamide or methysergide maleate in the treatment of chronic schizophrenia.
    Maire FW; Collins LG; Marks JB
    Int J Neuropsychiatry; 1967; 3(5):397-9. PubMed ID: 4866597
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
    Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR
    J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132
    [No Abstract]   [Full Text] [Related]  

  • 36. Thiothixene in chronic schizophrenia. A clinical trial.
    Yilmaz AH
    Hawaii Med J; 1971; 30(3):178-82. PubMed ID: 4935845
    [No Abstract]   [Full Text] [Related]  

  • 37. An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.
    Nakajima S; Uchida H; Suzuki T; Tomita M; Tsunoda K; Kitta M; Takeuchi H; Nomura K; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2007 Aug; 27(4):401-3. PubMed ID: 17632230
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled study of fluspirilene in chronic schizophrenia.
    Villeneuve A; Dogan K; Lachance R; Proulx C
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):819-27. PubMed ID: 4994687
    [No Abstract]   [Full Text] [Related]  

  • 39. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E; McKenna WJ; Gülker H; Krikler DM
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.